Results 141 to 150 of about 23,885,267 (262)
Quarterly Report to the Technology Assessment Board, July 1 - September 30, 1980
, 1980 This is a quarterly report detailing the budget and progress of the Office of Technology ...
Office of Technology Assessment
core
Beyond the algorithm: health technology assessment frameworks for AI in cardiology under the European Union Health Technology Assessment Regulation: a systematic review. [PDF]
Ann Transl MedOsoro L +7 more
europepmc +1 more source
Molecular Oncology, EarlyView.Tumour heterogeneity and clonal evolution of metastatic salivary gland cancer were evaluated in two patients with adenoid carcinoma and one patient with myoepithelial carcinoma. Radiology‐guided autopsy enabled multi‐region sampling (total samples n = 149), followed by whole‐genome sequencing and phylogenetic reconstruction (17 tumour samples, 4–7 per ...
Gerben Lassche +10 more
wiley +1 more source
Quarterly Report to the Technology Assessment Board, January 1 - March 31, 1980
, 1980 This is a quarterly report detailing the budget and progress of the Office of Technology ...
Office of Technology Assessment
core
Surrogate endpoints in cost-effectiveness analysis for use in health technology assessment - a qualitative analysis. [PDF]
Int J Technol Assess Health CareFlight L +7 more
europepmc +1 more source
Molecular Oncology, EarlyView.This study identifies somatostatin receptor 4 (Sstr4) as a critical tumor suppressor against skin and head/neck cancers (HNSCC, cSCC, and BCC). The loss of Sstr4 removes a check on cell growth, causing hyperactivation of the MAPK‐ERK signaling pathway (↑).
Ali Taqvi +6 more
wiley +1 more source
Quarterly Report to the Technology Assessment Board, October 1 - December 31, 1990
, 1991 This is a quarterly report detailing the budget and progress of the Office of Technology ...
Office of Technology Assessment
core
Introduction of early health technology assessment for innovators, clinicians, and funders. [PDF]
Npj Health SystWiwatpanit T, Teerawattananon Y, Wang Y.
europepmc +1 more source
Molecular Oncology, EarlyView.We show that emergence of castration‐resistant prostate (CRPC) is associated with significant upregulation of cyclins that positively regulate cyclin‐dependent kinase 2 (CDK2) and concomitant downregulation of CDK4 cyclins. This renders CRPC cells dependent on the high activity of CDK2, and CDK2 inhibitors synergistically sensitize CRPC cells to both ...
Joyeeta Chatterjee +3 more
wiley +1 more source
Quarterly Report to the Technology Assessment Board, January 1 - March 31, 1987
, 1987 Quarterly report to the Technology Assessment Board, detailing progress and budgets at ...
Office of Technology Assessment
core